AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
-20.7%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$6.67B
AUM Growth
-$4.04B
(-38%)
Cap. Flow
-$1.92B
Cap. Flow
% of AUM
-28.75%
Top 10 Holdings %
Top 10 Hldgs %
69.82%
Holding
636
New
124
Increased
62
Reduced
210
Closed
196
Top Buys
| 1 |
Wells Fargo
WFC
|
$411M |
| 2 |
Citigroup
C
|
$404M |
| 3 |
ICL Group
ICL
|
$396M |
| 4 |
JPMorgan Chase
JPM
|
$394M |
| 5 |
Bank of America
BAC
|
$390M |
Top Sells
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$2.02B |
| 2 |
Invesco QQQ Trust
QQQ
|
$1.72B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$995M |
| 4 |
KAHC
KKR Acquisition Holdings I Corp.
KAHC
|
$47.5M |
| 5 |
Herbalife
HLF
|
$31.9M |
Sector Composition
| 1 | Technology | 25.43% |
| 2 | Financials | 24.6% |
| 3 | Industrials | 10.58% |
| 4 | Materials | 6.19% |
| 5 | Communication Services | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Corcept Therapeutics
CORT
$7.31B
| $32K | ﹤0.01% |
1,364
-226
| -14% | -$5.3K |
|
302
Harmony Biosciences
HRMY
$2.07B
| $31K | ﹤0.01% |
642
-243
| -27% | -$11.7K |
|
303
Huron Consulting
HURN
$2.44B
| $31K | ﹤0.01% |
+478
| New | +$31K |
|
304
Ionis Pharmaceuticals
IONS
$9.76B
| $31K | ﹤0.01% |
+834
| New | +$31K |
|
305
Verint Systems
VRNT
$1.23B
| $31K | ﹤0.01% |
742
-257
| -26% | -$10.7K |
|
|
AVTA
306
DELISTED
Avantax, Inc. Common Stock
AVTA
| $31K | ﹤0.01% |
1,672
-2,708
| -62% | -$50.2K |
|
307
i3 Verticals
IIIV
$730M
| $30K | ﹤0.01% |
+1,205
| New | +$30K |
|
308
Prestige Consumer Healthcare
PBH
$3.2B
| $30K | ﹤0.01% |
515
-139
| -21% | -$8.1K |
|
309
Qiagen
QGEN
$10.3B
| $30K | ﹤0.01% |
589
-235
| -29% | -$12K |
|
310
Royalty Pharma
RPRX
$15.6B
| $30K | ﹤0.01% |
+707
| New | +$30K |
|
|
EVOP
311
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $30K | ﹤0.01% |
+1,283
| New | +$30K |
|
312
Broadridge
BR
$29.4B
| $29K | ﹤0.01% |
200
-39
| -16% | -$5.66K |
|
313
Cass Information Systems
CASS
$569M
| $29K | ﹤0.01% |
847
-33
| -4% | -$1.13K |
|
314
Chemed
CHE
$6.79B
| $29K | ﹤0.01% |
61
-18
| -23% | -$8.56K |
|
315
Edwards Lifesciences
EW
$47.5B
| $29K | ﹤0.01% |
301
-498
| -62% | -$48K |
|
316
Fastenal
FAST
$55.1B
| $29K | ﹤0.01% |
1,178
-216
| -15% | -$5.32K |
|
317
W.W. Grainger
GWW
$47.5B
| $29K | ﹤0.01% |
64
-35
| -35% | -$15.9K |
|
318
Morningstar
MORN
$10.8B
| $29K | ﹤0.01% |
120
-207
| -63% | -$50K |
|
319
Resources Connection
RGP
$167M
| $29K | ﹤0.01% |
1,416
-1,166
| -45% | -$23.9K |
|
320
S&P Global
SPGI
$164B
| $29K | ﹤0.01% |
86
-130
| -60% | -$43.8K |
|
321
Zoetis
ZTS
$67.9B
| $29K | ﹤0.01% |
168
-293
| -64% | -$50.6K |
|
322
Boston Scientific
BSX
$159B
| $28K | ﹤0.01% |
738
-162
| -18% | -$6.15K |
|
323
Cardinal Health
CAH
$35.7B
| $28K | ﹤0.01% |
542
-188
| -26% | -$9.71K |
|
324
CCC Intelligent Solutions
CCCS
$6.4B
| $28K | ﹤0.01% |
3,028
-239
| -7% | -$2.21K |
|
325
Donnelley Financial Solutions
DFIN
$1.55B
| $28K | ﹤0.01% |
939
-244
| -21% | -$7.28K |
|